Search by Drug Name or NDC

    NDC 00527-2580-32 Fluvastatin Sodium 80 mg/1 Details

    Fluvastatin Sodium 80 mg/1

    Fluvastatin Sodium is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is FLUVASTATIN SODIUM.

    Product Information

    NDC 00527-2580
    Product ID 0527-2580_0ead960b-0e48-cf8a-e063-6294a90aa925
    Associated GPIs 39400030107530
    GCN Sequence Number 046757
    GCN Sequence Number Description fluvastatin sodium TAB ER 24H 80 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 89424
    HICL Sequence Number 008946
    HICL Sequence Number Description FLUVASTATIN SODIUM
    Brand/Generic Generic
    Proprietary Name Fluvastatin Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fluvastatin Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 80
    Active Ingredient Units mg/1
    Substance Name FLUVASTATIN SODIUM
    Labeler Name Lannett Company, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209397
    Listing Certified Through 2025-12-31

    Package

    NDC 00527-2580-32 (00527258032)

    NDC Package Code 0527-2580-32
    Billing NDC 00527258032
    Package 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0527-2580-32)
    Marketing Start Date 2021-05-07
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.24133
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description FLUVASTATIN ER 80 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis